# Epiquinamide (Alkaloid)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/epiquinamide
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Compound
**Also Known As:** Epiquinamide, Novel quinolizidine alkaloid, Epipedobates tricolor alkaloid, Poison frog alkaloid, Quinolizidine derivative, Amphibian skin alkaloid

## Overview

Epiquinamide is a recently discovered alkaloid compound identified through natural product screening programs. The compound shows preliminary biological activity in initial bioassays, though its specific therapeutic mechanisms and clinical applications remain undefined.

## Health Benefits

• No clinical health benefits documented - compound remains in discovery phase with no human studies conducted
• Initial bioassay screening suggests biological activity, though specific therapeutic applications remain undefined
• As a recently discovered alkaloid, potential benefits require extensive research before any claims can be made
• No evidence quality available due to absence of clinical trials or therapeutic studies
• Current research limited to analytical chemistry and isolation methodology only

## Mechanism of Action

The specific molecular mechanisms of epiquinamide remain under investigation, as this alkaloid was only recently isolated and characterized. Initial bioassay screening suggests the compound demonstrates biological activity, though the specific cellular targets, receptor interactions, and enzymatic pathways have not been fully elucidated. Further research is needed to determine whether epiquinamide modulates specific [neurotransmitter](/ingredients/condition/cognitive) systems, [inflammatory pathway](/ingredients/condition/inflammation)s, or other molecular targets.

## Clinical Summary

No human clinical trials have been conducted with epiquinamide, as this alkaloid remains in the early discovery phase of research. The compound has undergone preliminary bioassay screening that indicates potential biological activity, though these studies have not been published or peer-reviewed. Without human studies, clinical efficacy, optimal dosing ranges, and therapeutic applications cannot be determined. The research status of epiquinamide is similar to thousands of other natural compounds that show initial promise but require extensive investigation before any health claims can be substantiated.

## Nutritional Profile

Epiquinamide is a bicyclic quinolizidine alkaloid compound (C13H20N2O) isolated in trace quantities from the skin secretions of the Ecuadorian frog Epipedobates tricolor, with a molecular weight of 220.31 g/mol. It is not a nutritional ingredient and contains no macronutrients (zero protein, carbohydrate, fat, or fiber content in any dietary sense). No vitamins or minerals are inherently associated with this compound. As a pure alkaloid, it exists as a discrete small molecule rather than a nutrient source. The bioactive component of interest is the quinolizidine core structure with an exo-2-enamide side chain, which has demonstrated nicotinic [acetylcholine](/ingredients/condition/cognitive) receptor (nAChR) agonist activity in preliminary bioassays at micromolar concentrations. Concentrations found naturally in frog skin secretions are extremely low (microgram-per-gram range). Bioavailability data in humans is entirely absent; no pharmacokinetic studies (absorption, distribution, [metabolism](/ingredients/condition/weight-management), excretion) have been conducted. The compound is structurally distinct from nutritive alkaloids and should be classified solely as a pharmacologically investigated small molecule, not a dietary or nutritional substance.

## Dosage & Preparation

No clinically studied dosage ranges are available for epiquinamide in any formulation. The compound remains in early research phase without established clinical dosing protocols. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

The safety profile of epiquinamide has not been established, as no toxicology studies or human safety trials have been conducted. Potential drug interactions, contraindications, and adverse effects remain completely unknown due to the compound's early research status. Pregnancy and lactation safety cannot be assessed without proper safety studies and clinical data. As with any uncharacterized alkaloid compound, epiquinamide should be considered potentially hazardous until comprehensive safety evaluation is completed.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for epiquinamide have been conducted. The available literature documents only the initial discovery and isolation of this novel compound from frog skin extracts, focusing on analytical chemistry rather than clinical applications.

## Historical & Cultural Context

Epiquinamide has no documented traditional medicine history. As a recently discovered alkaloid from amphibian skin secretions, it lacks the historical context of traditional medicinal use found in plant-derived alkaloids.

## Synergistic Combinations

None established - compound lacks interaction studies

## Frequently Asked Questions

### What is epiquinamide used for?

Epiquinamide currently has no established therapeutic uses, as it remains in the discovery phase of research. The compound has shown preliminary biological activity in initial screening, but specific applications have not been identified or validated through clinical studies.

### Is epiquinamide safe to take?

The safety of epiquinamide is completely unknown, as no toxicology studies or human safety trials have been conducted. Without proper safety evaluation, this alkaloid should be considered potentially hazardous and is not recommended for human consumption.

### Where does epiquinamide come from?

Epiquinamide is a naturally occurring alkaloid that was recently discovered through natural product screening programs. The specific plant or organism source of this compound has not been widely documented in published literature.

### Can I buy epiquinamide supplements?

Epiquinamide is not available as a commercial supplement, as it remains an experimental research compound. The alkaloid has not been approved by regulatory agencies and lacks the safety and efficacy data required for consumer products.

### How much epiquinamide should I take?

There is no established dosage for epiquinamide, as no human studies have been conducted to determine safe or effective amounts. Without clinical data, any dosage recommendations would be purely speculative and potentially dangerous.

### What does clinical research show about epiquinamide?

Epiquinamide remains in the discovery phase with no human clinical trials completed to date. Currently, only initial bioassay screening studies suggest the compound may have biological activity, but specific therapeutic applications have not been identified or validated. Extensive research is required before any health claims can be substantiated or recommended for human use.

### Who should avoid epiquinamide supplements?

Due to the absence of clinical safety data, epiquinamide should be avoided by pregnant women, nursing mothers, children, and individuals with compromised immune systems until human studies are conducted. People taking prescription medications should consult a healthcare provider before use, as potential drug interactions have not been studied. Anyone with underlying health conditions should seek medical advice before considering this supplement.

### What is the difference between epiquinamide and other alkaloids?

Epiquinamide is a recently discovered alkaloid that differs from well-studied alkaloids like caffeine or berberine in that it has no documented clinical benefits or established biological targets in humans. While many traditional alkaloids have centuries of use or decades of research supporting their effects, epiquinamide's specific mechanisms and potential applications remain completely undefined. Its classification as a bioactive compound is based solely on preliminary laboratory screening rather than proven physiological activity.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*